🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 7 Days
›
Biotechnology Industry
Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(17)
All (139)
Buys (17)
Sells (122)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Rapport Therapeutics, Inc.
(RAPP)
Sanchez Ramiro
— Director
Oct 23, 2026
Purchase
Shares
3,600
Price
$27.35
Total Value
$98.48K
Shares Held After
3,600
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
AIM ImmunoTech Inc.
(AIM)
Equels Thomas K
— Director
Oct 22, 2026
Purchase
Shares
31,250
Price
$0.16
Total Value
$5.09K
Shares Held After
158,072
% of Holdings
19.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Anixa Biosciences Inc
(ANIX)
KUMAR AMIT
— Director
Oct 22, 2026
Purchase
Shares
8,000
Price
$2.72
Total Value
$21.76K
Shares Held After
680,000
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rapport Therapeutics, Inc.
(RAPP)
PAUL STEVEN M
— Director
Oct 22, 2026
Purchase
Shares
35,714
Price
$27.28
Total Value
$974.28K
Shares Held After
77,380
% of Holdings
46.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rapport Therapeutics, Inc.
(RAPP)
MARAGANORE JOHN
— Director
Oct 22, 2026
Purchase
Shares
1,172
Price
$26.92
Total Value
$31.55K
Shares Held After
9,411
% of Holdings
12.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rapport Therapeutics, Inc.
(RAPP)
MARAGANORE JOHN
— Director
Oct 22, 2026
Purchase
Shares
8,239
Price
$26.38
Total Value
$217.34K
Shares Held After
8,239
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rapport Therapeutics, Inc.
(RAPP)
Silva Paul M
— Director
Oct 22, 2026
Purchase
Shares
3,680
Price
$27.07
Total Value
$99.64K
Shares Held After
3,680
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rapport Therapeutics, Inc.
(RAPP)
Young Wendy B.
— Director
Oct 22, 2026
Purchase
Shares
3,789
Price
$26.39
Total Value
$99.99K
Shares Held After
13,289
% of Holdings
28.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rapport Therapeutics, Inc.
(RAPP)
Ignelzi Troy A.
— Chief Financial Officer
Oct 21, 2026
Purchase
Shares
5,500
Price
$26.10
Total Value
$143.55K
Shares Held After
15,500
% of Holdings
35.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TENAX THERAPEUTICS, INC.
(TENX)
ADAR1 Capital Management, LLC
— 10% Owner
Oct 21, 2026
Purchase
Shares
331,979
Price
$1.66
Total Value
$550.69K
Shares Held After
7,447,000
% of Holdings
4.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TENAX THERAPEUTICS, INC.
(TENX)
ADAR1 Capital Management, LLC
— 10% Owner
Oct 20, 2026
Purchase
Shares
254,342
Price
$1.60
Total Value
$405.73K
Shares Held After
7,115,021
% of Holdings
3.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Boundless Bio, Inc.
(BOLD)
TANG KEVIN
— 10% Owner
Oct 20, 2026
Purchase
Shares
220
Price
$2.37
Total Value
$521.40
Shares Held After
2,990,109
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Grace Therapeutics, Inc.
(GRCE)
Opaleye Management Inc.
— 10% Owner
Oct 19, 2026
Purchase
Shares
4,256
Price
$1.88
Total Value
$8.00K
Shares Held After
2,948,610
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TENAX THERAPEUTICS, INC.
(TENX)
ADAR1 Capital Management, LLC
— 10% Owner
Oct 19, 2026
Purchase
Shares
336,528
Price
$1.51
Total Value
$507.01K
Shares Held After
6,860,679
% of Holdings
4.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Boundless Bio, Inc.
(BOLD)
TANG KEVIN
— 10% Owner
Oct 19, 2026
Purchase
Shares
18,279
Price
$2.33
Total Value
$42.59K
Shares Held After
2,989,889
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Boundless Bio, Inc.
(BOLD)
TANG KEVIN
— 10% Owner
Oct 19, 2026
Purchase
Shares
12,790
Price
$2.34
Total Value
$29.93K
Shares Held After
2,971,610
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
InMed Pharmaceuticals Inc.
(INM)
ADAR1 Capital Management, LLC
— 10% Owner
Oct 19, 2026
Purchase
Shares
1,086
Price
$1.32
Total Value
$1.43K
Shares Held After
956,580
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
17 transactions
Version: v26.10.12